Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
46.50
-2.46 (-5.02%)
Nov 21, 2024, 4:00 PM EST - Market closed

Janux Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Market Capitalization
2,440495547821--
Market Cap Growth
409.79%-9.51%-33.35%---
Enterprise Value
1,935170233434--
Last Close Price
48.9610.7313.1719.73--
PS Ratio
192.1661.2663.54225.73--
PB Ratio
3.911.441.712.24--
P/TBV Ratio
3.611.441.712.24--
EV/Sales Ratio
148.2721.0827.00119.25--
Debt / Equity Ratio
0.040.070.080.00--1.01
Asset Turnover
0.020.020.020.02--
Quick Ratio
38.5826.5719.8529.324.970.14
Current Ratio
38.8026.8020.1429.465.050.14
Return on Equity (ROE)
-12.05%-17.53%-18.36%-17.50%-446.61%-
Return on Assets (ROA)
-9.93%-12.25%-11.27%-10.39%-35.83%-
Return on Capital (ROIC)
-10.20%-12.76%-11.77%-11.02%-86.02%-
Earnings Yield
-2.36%-11.77%-11.52%-3.98%--
FCF Yield
-1.47%-10.59%-9.02%-2.25%--
Buyback Yield / Dilution
-19.85%-6.14%-76.24%-2471.20%-36.71%-
Total Shareholder Return
-19.85%-6.14%-76.24%-2471.20%-36.71%-
Source: S&P Capital IQ. Standard template. Financial Sources.